2-amino-1-(4-(3-(3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl)ureido)phenyl)-1H-pyrrolo[2,3-b]quinoxaline-3-carboxamide

ID: ALA4784484

PubChem CID: 118402526

Max Phase: Preclinical

Molecular Formula: C34H30N10O2

Molecular Weight: 610.68

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3c(N)c(C(N)=O)c4nc5ccccc5nc43)cc2)n(-c2ccc3ncccc3c2)n1

Standard InChI:  InChI=1S/C34H30N10O2/c1-34(2,3)26-18-27(44(42-26)22-14-15-23-19(17-22)7-6-16-37-23)41-33(46)38-20-10-12-21(13-11-20)43-30(35)28(31(36)45)29-32(43)40-25-9-5-4-8-24(25)39-29/h4-18H,35H2,1-3H3,(H2,36,45)(H2,38,41,46)

Standard InChI Key:  CCNDYGMHSHSKIW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 46 52  0  0  0  0  0  0  0  0999 V2000
   16.5653  -14.1440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5641  -14.9635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2722  -15.3725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2704  -13.7351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9790  -14.1404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9798  -14.9594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6883  -15.3665    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.6827  -13.7301    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.3918  -14.1335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3949  -14.9526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1749  -15.2028    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.6539  -14.5383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1699  -13.8775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4711  -14.5352    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.4195  -13.0994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2182  -12.9264    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.8704  -12.4942    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.4306  -15.9758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8843  -16.5851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1392  -17.3607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9399  -17.5282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4853  -16.9140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2276  -16.1407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1964  -18.3041    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.9966  -18.4700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2530  -19.2459    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.5403  -17.8599    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.0532  -19.4118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3896  -20.1533    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.2018  -20.0637    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.3677  -19.2635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6579  -18.8586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1125  -18.9273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7761  -19.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1937  -18.1141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8158  -18.5106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9855  -20.8613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1672  -20.8649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9973  -22.2729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3978  -21.5630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1759  -22.2804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7668  -21.5755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9536  -21.5783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5485  -22.2853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9626  -22.9909    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7744  -22.9847    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7 10  2  0
  9  8  2  0
  8  5  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13  9  1  0
 12 14  1  0
 13 15  1  0
 15 16  1  0
 15 17  2  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 11 18  1  0
 21 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  2  0
 26 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 28  2  0
 31 33  1  0
 33 34  1  0
 33 35  1  0
 33 36  1  0
 37 38  2  0
 38 42  1  0
 41 39  1  0
 39 40  2  0
 40 37  1  0
 29 37  1  0
 41 42  1  0
 42 43  2  0
 43 44  1  0
 44 45  2  0
 45 46  1  0
 46 41  2  0
M  END

Associated Targets(Human)

EPHA3 Tchem Ephrin type-A receptor 3 (1582 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EPHB4 Tchem Ephrin type-B receptor 4 (3198 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Maver1 (85 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JeKo-1 (376 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 610.68Molecular Weight (Monoisotopic): 610.2553AlogP: 5.93#Rotatable Bonds: 5
Polar Surface Area: 171.66Molecular Species: NEUTRALHBA: 9HBD: 4
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 6#RO5 Violations (Lipinski): 4
CX Acidic pKa: 11.56CX Basic pKa: 4.68CX LogP: 6.20CX LogD: 6.20
Aromatic Rings: 7Heavy Atoms: 46QED Weighted: 0.19Np Likeness Score: -1.72

References

1. Unzue, Andrea, Jessen-Trefzer, Claudia, Spiliotopoulos, Dimitrios, Gaudio, Eugenio, Tarantelli, Chiara, Dong, Jing, Zhao, Hongtao, Pachmayr, Johanna, Zahler, Stefan, Bernasconi, Elena, Sartori, Giulio, Cascione, Luciano, Bertoni, Francesco, Sledz, Pawel, Caflisch, Amedeo, Nevado, Cristina.  (2020)  Understanding the mechanism of action of pyrrolo[3,2-b]quinoxaline-derivatives as kinase inhibitors,  11  (6): [PMID:33479666] [10.1039/d0md00049c]

Source